Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
BioLineRx to initiate Phase 1/2 clinical trial on new drug candidate for CML treatment

BioLineRx to initiate Phase 1/2 clinical trial on new drug candidate for CML treatment

Affimed Therapeutics reports additional results from AFM13 phase 1 study on R/R Hodgkin lymphoma

Affimed Therapeutics reports additional results from AFM13 phase 1 study on R/R Hodgkin lymphoma

Researchers receive NIH grant for pediatric acute myelogenous leukemia treatment

Researchers receive NIH grant for pediatric acute myelogenous leukemia treatment

Study shows critical role of immune system in protecting against viruses and cancer cells

Study shows critical role of immune system in protecting against viruses and cancer cells

Researchers identify experimental drugs to block treatment-resistant leukemia

Researchers identify experimental drugs to block treatment-resistant leukemia

Janssen submits supplemental New Drug Application for IMBRUVICA to the U.S. FDA

Janssen submits supplemental New Drug Application for IMBRUVICA to the U.S. FDA

Ambit initiates QUANTUM-R Phase 3 clinical trial of quizartinib in FLT3-ITD positive AML patients

Ambit initiates QUANTUM-R Phase 3 clinical trial of quizartinib in FLT3-ITD positive AML patients

DelMar presents pre-clinical study data that evaluates activity of VAL-083 in drug-resistant NSCLC

DelMar presents pre-clinical study data that evaluates activity of VAL-083 in drug-resistant NSCLC

Bezos family gifts $20M to Fred Hutchinson scientists for development of novel cancer immunotherapies

Bezos family gifts $20M to Fred Hutchinson scientists for development of novel cancer immunotherapies

NRAS gene that plays fundamental role in cancer development produces five gene variants, says study

NRAS gene that plays fundamental role in cancer development produces five gene variants, says study

Ambit initiates Phase 2 study of quizartinib in acute myeloid leukemia patients

Ambit initiates Phase 2 study of quizartinib in acute myeloid leukemia patients

Study looks at ability of nontoxic molecules to store harmful alpha emitting radioisotopes

Study looks at ability of nontoxic molecules to store harmful alpha emitting radioisotopes

FDA grants orphan drug designation to ERYTECH’s lead product for AML treatment

FDA grants orphan drug designation to ERYTECH’s lead product for AML treatment

Evotec signs research collaboration and licensing deal with Debiopharm Group

Evotec signs research collaboration and licensing deal with Debiopharm Group

CytRx’s aldoxorubicin receives European orphan medicinal product designation for treatment of advanced soft tissue sarcomas

CytRx’s aldoxorubicin receives European orphan medicinal product designation for treatment of advanced soft tissue sarcomas

Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

Clinigen Group announces acquisition of SAVENE oncology support therapy from SpePharm

Clinigen Group announces acquisition of SAVENE oncology support therapy from SpePharm

Einstein faculty members present recent research at AACR Annual Meeting

Einstein faculty members present recent research at AACR Annual Meeting

Researchers find new drug target for mitochondrial dysfunction

Researchers find new drug target for mitochondrial dysfunction

Scientists move a step closer to preserving fertility in young boys with cancer

Scientists move a step closer to preserving fertility in young boys with cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.